buletin bil 1/2017
TRANSCRIPT
BULETIN BIL 1/2017
POMs
TPN
ADR
Pensijilan 5S
PRP Kontrak
FAQ
Welcome & Farewell
Editorial Board Advisor
Pn Hjh Rohayah Binti
Abd Ghani
Chief Editors
Pn Roslita Binti Alivi
Pn Tan Pei Li
Pn Shafika Hanim
Pn Nurul Balqis Riza
Cik Sharifah Sadiqa
Editors
Aminur Anuar
Ahmad Khidir
Chan Shu Ting
Cheah Cui Yi
Diana Wong
Parenteral nutrition therapy is defined as therapeutic intravenous administration of nutrients such as amino acids, glu-
cose, lipids, electrolytes, vitamins and trace elements to a patient when oral or enteral nutrition is inadequate (due to poor
absorption), impossible (due to bowel obstruction) or undesirable (due to deep coma or necessity for bowel rest). It can be
Definition of Parenteral Nutrition (PN)
PN products available in Pharmacy Department, HSI
Total Parenteral Nutrition
Total parenteral nutrition (TPN) Partial parenteral nutrition (PPN)
Refers to situation where the patient’s complete
nutritional needs (all macro and micronutrients) are cov-
ered by PN, and in which nutrition is not given by any
route other than intravenously
Refers to situation where nutrition is provided in ad-
dition to parenteral nutrition by any route other than
intravenously. For example, when the oral or enteral
tube routes cannot independently achieve the defined
nutritional care plan target
Table 1: Examples of pre-mixed PN available for adults.
Types of Parenteral Nutrition (PN)
Product name
SmofKabiven® Nutriflex® Lipid
SmofKabiven®
Central
SmofKabiven®
Peripheral
Nutriflex®
Lipid Peri
Nutriflex®
Lipid Special
Route Central
Central/
Peripheral
Central/
Peripheral Central
Volume (ml) 1477 1448 ml 1875 625
Total energy, (kcal) 1600 1000 1435 740
Amino acids (g) 75 46 60 36
Nitrogen (g) 12 7.4 9 5
Taurine (g) 0.75 0.46 - -
Glucose (g) 187 103 120 90
Lipids (g) 56 41 75 25
Fish oil, rich in omega-3-acids (g) 8.4 6.1 - -
Non-protein calories (kcal) 1300 800 1195 598
Ration energy from glucose: lipid 58:42 50:50 40:60 60:40
Osmolarity 1500 850 840 1545
ADVERSE DRUG REACTION
Olanzapine: Risk of Drug Reaction with Eosinophilia and
Systemic Symptoms (DRESS)
Since year 2000, the NPRA has received 283
ADR reports with 488 adverse events
suspected to be related to olanzapine.
There were four reports (0.8%) involving se-
vere cutaneous adverse reactions (SCARs),
In Hospital Sultan Ismail Johor Bahru, there
were one case reported on 2016.
Patient develop bilateral leg swelling and facial
swelling after taking T.olanzapine 5 mg.
The U.S. FDA is warning that the antipsychotic
medicine olanzapine can cause a rare but seri-
ous skin reaction that can progress to affect
other parts of the body. We are adding a new
warning to the drug labels for all olanzapine-
containing products that describes this severe
condition known as Drug Reaction with Eosin-
ophilia and Systemic Symptoms (DRESS)
DRESS is used to describe a severe drug hyper-
sensitivity eruption associated with constitu-
tional symptoms, such as fever, malaise,
A review of the FDA Adverse Event Reporting
System (FAERS) revealed 23 cases of DRESS as-
sociated with olanzapine use
The median dose of olanzapine was reported
If DRESS is suspected, stop treatment with olanzapine. Management of DRESS includes early
recognition of the symptoms, discontinuation of the offending drug and supportive care.
Advise patients taking olanzapine to seek medical attention if they experience the
following symptoms: fever, rash, swollen lymph glands, or face swelling.
Local Report Global Report
Report in HSIJB
Advices
Pensijilan 5S Ke arah Pensijilan 5S pada tahun 2017
Audit Pensijilan 5S oleh wakil MPC pada 28 Februari 2017
Farmasi Logistik
Farmasi Pesakit Luar Farmasi Pesakit Dalam
‘Semoga Amalan 5S memastikan suasana bekerja yang kondusif dan teratur’
Aktiviti 5S oleh JK farmasi:
Countdown
Hari Sisih
Permainan dan quiz
Tahniah kepada Jabatan Farmasi HSIJB kerana berjaya mendapatkan Pensijilan
5S untuk tempoh 1 tahun (28 Feb 2017—27 Feb 2018)
Zon Winter
Zon Summer Zon Autumn
Zon Summer
Perubahan Zon: Inovasi
“Kerana kekangan jawatan tetap, Kerajaan mengambil keputusan melantik secara kontrak kumpulan pertama
graduan perubatan, pergigian dan farmasi selewat-lewatnya Disember 2016.” – Ucapan Bajet 2017
PRP KONTRAK
Tidak mengisi jawatan
Pelantikan secara kontrak bertujuan: Latihan Siswazah dan/atau Khidmat Wajib
Tarikh kuatkuasa: 1 Disember 2016
Tempoh kontrak yang diluluskan:
Dasar Pelantikan Kontrak
Skim/ Jawatan Tempoh Maksima Jumlah
Keseluruhan Latihan Siswazah Khidmat Wajib
Pegawai Farmasi
Gred UF41
2 tahun 1 tahun 3 tahun
1. Tamat pengajian
2. Permohonan Sijil Pendaftaran dengan Lembaga Farmasi Malaysia
3. Permohonan Suruhanjaya Perkhidmatan Awam (SPA)
4. Hadir Temuduga oleh SPA
5. Permohanan penempatan melalui system e-Pharmacist
6. MenyedIa dan melengkapkan Borang PerjanjIan dan Dokumen Pelantikan Kontrak
7. Lapor diri menghadiri Program Transformasi Minda (PTM)
8. Lapor diri bertugas di hospital
Latar Belakang
Proses Pelantikan Kontrak
•Memenuhi tahap kesihatan
•Memenuhi syarat lantikan seperti dalam skim perkhidmatan
•Mempunyai tatakelakuan yang memuaskan
Syarat Pelantikan
•Telah menjalani pemeriksaaan kesihatan •Membuat Akuan Berkanun
•Telah tandatangani Surat Aku Janji •Mengisi borang dan lulus Tapisan
Keselamatan
Syarat
Pelantikan
Pertama
Syarat
Pelantikan
Tetap
Syarat
Pelantikan
Semula
•Pelantikan mengikut susunan merit
•Menjalani dengan jayanya latihan siswazah/ memenuhi syarat khidmat wajib dan syarat pengesahan dalam perkhidmatan:
1. Syarat minimum tempoh percubaan selama 1 tahun
2. Hadir dengan jaya ProgramTransfromasi Minda (PTM)
3. Perakuan Ketua Jabatan/ Ketua perkhidmatan
4. Prestasi sekurang-kurangnya purata 85%